Santhera to Announce 2020 Results on April 29, 2021
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results on Thursday, April 29, 2021, at...
Year: 2021
Microbix Receives $4.25 Million Order For Viral Transport Medium
An Initial Order From Government Of Ontario Procurement AuthoritiesMISSISSAUGA, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under...
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young...
Dermatology Experts Present Latest Information at AAD VMX 2021
ROSEMONT, Ill., April 23, 2021 (GLOBE NEWSWIRE) -- The AAD VMX 2021, a virtual meeting experience taking place April 23-25,...
Arcutis Biotherapeutics Showcases New Roflumilast Data in Psoriasis and Seborrheic Dermatitis at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021
Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured in late-breaking oral presentationData demonstrate...
Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential Treatment for Primary Axillary Hyperhidrosis
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful...
Valley Oaks Medical Group: Healthcare Made Affordable for Medicare-Eligible Seniors
LAS VEGAS, NV / ACCESSWIRE / April 23, 2021 / Barriers are affecting senior citizens from getting the help they need...
CENTR Brands Corp. Signs Distribution Agreement with Southern Glazer’s Wine & Spirits
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Capital Rx Named Winner of 2021 Edison Award
Company’s Clearinghouse ModelTM, Designed to Simplify Prescription Drug Pricing, Captures Silver Award NEW YORK--(BUSINESS WIRE)--Capital Rx, the fastest-growing pharmacy benefit...
Cloud DX Awarded Silver at the 2021 Edison Awards
BROOKLYN, NY and KITCHENER, ON / ACCESSWIRE / April 23, 2021 / Cloud DX (TSXV:CDX) a leading provider of virtual care and...
Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014HAMBURG, GERMANY / ACCESSWIRE /...
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising...
DLH Wins Follow-On Contract for CMOP Medical Logistics for the Department of Veterans Affairs
Five Year Value of $202 MillionATLANTA, April 23, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the...
Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
REDWOOD CITY, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS) has received notice from immuno-oncology partner...
Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021
TORONTO, April 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will...
Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of the Board of Directors
- Edward J. Sitar appointed as Lead Independent Director of the Board - - Company establishes Science and Technology Committee...
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant...
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
Company to conduct additional clinical study to support submission of a Biologics License Application for TARA-002 in Lymphatic MalformationsNEW YORK,...
CHMP recommends EU approval of Roche’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
If approved, ENSPRYNG will be the first and only treatment available to both adults and adolescents from 12 years of...